Richard D Kennedy, MD - Medicare Family Practice in Columbia, TN

Richard D Kennedy, MD is a medicare enrolled "Family Medicine" physician in Columbia, Tennessee. He went to Meharry Medical College School Of Medicine and graduated in 1998 and has 26 years of diverse experience with area of expertise as Family Practice. He is a member of the group practice Advanced Diagnostic Imaging Pc and his current practice location is 1609 Rosewood Dr, Columbia, Tennessee. You can reach out to his office (for appointments etc.) via phone at (931) 388-8802.

Richard D Kennedy is licensed to practice in Tennessee (license number 34124) and he also participates in the medicare program. He accepts medicare assignments (which means he accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and his NPI Number is 1215029897.

Contact Information

Richard D Kennedy, MD
1609 Rosewood Dr,
Columbia, TN 38401-6420
(931) 388-8802
(931) 490-2292



Physician's Profile

Full NameRichard D Kennedy
GenderMale
SpecialityFamily Practice
Experience26 Years
Location1609 Rosewood Dr, Columbia, Tennessee
Accepts Medicare AssignmentsYes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.
  Medical Education and Training:
  • Richard D Kennedy attended and graduated from Meharry Medical College School Of Medicine in 1998
  NPI Data:
  • NPI Number: 1215029897
  • Provider Enumeration Date: 09/29/2006
  • Last Update Date: 08/01/2023
  Medicare PECOS Information:
  • PECOS PAC ID: 3476545195
  • Enrollment ID: I20040401001272

Medical Identifiers

Medical identifiers for Richard D Kennedy such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1215029897NPI-NPPES
1512603MedicaidTN
3850826MedicaidTN
38508261MedicaidTN
3710089MedicaidTN
4021933OtherTNBCBSTN

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
207Q00000XFamily Medicine 34124 (Tennessee)Primary

Medical Facilities Affiliation

Facility NameLocationFacility Type
Amedisys Home Health CareSmyrna, TNHome health agency
Nhc Homecare ColumbiaColumbia, TNHome health agency
Avalon HospiceNashville, TNHospice
Maury Regional HospitalColumbia, TNHospital
Marshall Medical CenterLewisburg, TNHospital
Nhc-maury Regional Transitional Care CenterColumbia, TNNursing home
Life Care Center Of ColumbiaColumbia, TNNursing home
Magnolia Healthcare And Rehabilitation CenterColumbia, TNNursing home

Group Practice Association

Group Practice NameGroup PECOS PAC IDNo. of Members
Advanced Diagnostic Imaging Pc7315848140545

News Archive

Comprehensive review of clioquinol drug gives valuable insights

CQ is an old drug that was commonly used to treat fungal/protozoal infections of the gastrointestinal tract. Patients in Japan taking it developed subacute myelo-optic neuropathy which resulted in CQ being discontinued for oral use. Recently, extensive research has been done in regards to CQ's use for cancer treatment.

FDA approves first drug for patients with hypereosinophilic syndrome in nearly 14 years

Today, the U.S. Food and Drug Administration approved Nucala (mepolizumab) for adults and children aged 12 years and older with hypereosinophilic syndrome (HES) for six months or longer without another identifiable non-blood related cause of the disease.

New York Times examines India's growing influence on global drug industry

"India's drug industry — on track to grow about 13 percent this year, to just over $24 billion — was once notorious for making cheap knockoffs of Western medicines and selling them in developing countries. But India, seasoned in the basics of medicine making, is now starting to take on a more mainstream role in the global drug industry, as a result of recent strengthening of patent law here and cost pressures on name-brand drug makers in the West," the New York Times writes.

Clovis Oncology reports net loss of $15.7 million for second quarter 2012

Clovis Oncology, Inc. today reported financial results for the second quarter 2012, and provided an update on the progress of its clinical development programs and expected milestones for the rest of the year.

Bush says he will sign PEPFAR reauthorization

President Bush on Saturday during his weekly radio address said he is eager to sign legislation (HR 5501) that would reauthorize the President's Emergency Plan for AIDS Relief through 2013, the AP/Google.com reports (Reichmann, AP/Google.com, 7/26).

Read more Medical News

› Verified 7 days ago

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Richard D Kennedy allows following entities to bill medicare on his behalf.
Entity NameSaint Thomas Medical Partners
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1437194669
PECOS PAC ID: 1557269354
Enrollment ID: O20031230000470

News Archive

Comprehensive review of clioquinol drug gives valuable insights

CQ is an old drug that was commonly used to treat fungal/protozoal infections of the gastrointestinal tract. Patients in Japan taking it developed subacute myelo-optic neuropathy which resulted in CQ being discontinued for oral use. Recently, extensive research has been done in regards to CQ's use for cancer treatment.

FDA approves first drug for patients with hypereosinophilic syndrome in nearly 14 years

Today, the U.S. Food and Drug Administration approved Nucala (mepolizumab) for adults and children aged 12 years and older with hypereosinophilic syndrome (HES) for six months or longer without another identifiable non-blood related cause of the disease.

New York Times examines India's growing influence on global drug industry

"India's drug industry — on track to grow about 13 percent this year, to just over $24 billion — was once notorious for making cheap knockoffs of Western medicines and selling them in developing countries. But India, seasoned in the basics of medicine making, is now starting to take on a more mainstream role in the global drug industry, as a result of recent strengthening of patent law here and cost pressures on name-brand drug makers in the West," the New York Times writes.

Clovis Oncology reports net loss of $15.7 million for second quarter 2012

Clovis Oncology, Inc. today reported financial results for the second quarter 2012, and provided an update on the progress of its clinical development programs and expected milestones for the rest of the year.

Bush says he will sign PEPFAR reauthorization

President Bush on Saturday during his weekly radio address said he is eager to sign legislation (HR 5501) that would reauthorize the President's Emergency Plan for AIDS Relief through 2013, the AP/Google.com reports (Reichmann, AP/Google.com, 7/26).

Read more Medical News

› Verified 7 days ago

Entity NameAdvanced Diagnostic Imaging Pc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1093741464
PECOS PAC ID: 7315848140
Enrollment ID: O20040115000677

News Archive

Comprehensive review of clioquinol drug gives valuable insights

CQ is an old drug that was commonly used to treat fungal/protozoal infections of the gastrointestinal tract. Patients in Japan taking it developed subacute myelo-optic neuropathy which resulted in CQ being discontinued for oral use. Recently, extensive research has been done in regards to CQ's use for cancer treatment.

FDA approves first drug for patients with hypereosinophilic syndrome in nearly 14 years

Today, the U.S. Food and Drug Administration approved Nucala (mepolizumab) for adults and children aged 12 years and older with hypereosinophilic syndrome (HES) for six months or longer without another identifiable non-blood related cause of the disease.

New York Times examines India's growing influence on global drug industry

"India's drug industry — on track to grow about 13 percent this year, to just over $24 billion — was once notorious for making cheap knockoffs of Western medicines and selling them in developing countries. But India, seasoned in the basics of medicine making, is now starting to take on a more mainstream role in the global drug industry, as a result of recent strengthening of patent law here and cost pressures on name-brand drug makers in the West," the New York Times writes.

Clovis Oncology reports net loss of $15.7 million for second quarter 2012

Clovis Oncology, Inc. today reported financial results for the second quarter 2012, and provided an update on the progress of its clinical development programs and expected milestones for the rest of the year.

Bush says he will sign PEPFAR reauthorization

President Bush on Saturday during his weekly radio address said he is eager to sign legislation (HR 5501) that would reauthorize the President's Emergency Plan for AIDS Relief through 2013, the AP/Google.com reports (Reichmann, AP/Google.com, 7/26).

Read more Medical News

› Verified 7 days ago

Entity NameMid -tennessee Family Health Center
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1750456414
PECOS PAC ID: 0345467643
Enrollment ID: O20140811001024

News Archive

Comprehensive review of clioquinol drug gives valuable insights

CQ is an old drug that was commonly used to treat fungal/protozoal infections of the gastrointestinal tract. Patients in Japan taking it developed subacute myelo-optic neuropathy which resulted in CQ being discontinued for oral use. Recently, extensive research has been done in regards to CQ's use for cancer treatment.

FDA approves first drug for patients with hypereosinophilic syndrome in nearly 14 years

Today, the U.S. Food and Drug Administration approved Nucala (mepolizumab) for adults and children aged 12 years and older with hypereosinophilic syndrome (HES) for six months or longer without another identifiable non-blood related cause of the disease.

New York Times examines India's growing influence on global drug industry

"India's drug industry — on track to grow about 13 percent this year, to just over $24 billion — was once notorious for making cheap knockoffs of Western medicines and selling them in developing countries. But India, seasoned in the basics of medicine making, is now starting to take on a more mainstream role in the global drug industry, as a result of recent strengthening of patent law here and cost pressures on name-brand drug makers in the West," the New York Times writes.

Clovis Oncology reports net loss of $15.7 million for second quarter 2012

Clovis Oncology, Inc. today reported financial results for the second quarter 2012, and provided an update on the progress of its clinical development programs and expected milestones for the rest of the year.

Bush says he will sign PEPFAR reauthorization

President Bush on Saturday during his weekly radio address said he is eager to sign legislation (HR 5501) that would reauthorize the President's Emergency Plan for AIDS Relief through 2013, the AP/Google.com reports (Reichmann, AP/Google.com, 7/26).

Read more Medical News

› Verified 7 days ago

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Richard D Kennedy is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Richard D Kennedy, MD
3024 Business Park Cir,
Goodlettsville, TN 37072-3132

Ph: (615) 239-2018
Richard D Kennedy, MD
1609 Rosewood Dr,
Columbia, TN 38401-6420

Ph: (931) 388-8802

News Archive

Comprehensive review of clioquinol drug gives valuable insights

CQ is an old drug that was commonly used to treat fungal/protozoal infections of the gastrointestinal tract. Patients in Japan taking it developed subacute myelo-optic neuropathy which resulted in CQ being discontinued for oral use. Recently, extensive research has been done in regards to CQ's use for cancer treatment.

FDA approves first drug for patients with hypereosinophilic syndrome in nearly 14 years

Today, the U.S. Food and Drug Administration approved Nucala (mepolizumab) for adults and children aged 12 years and older with hypereosinophilic syndrome (HES) for six months or longer without another identifiable non-blood related cause of the disease.

New York Times examines India's growing influence on global drug industry

"India's drug industry — on track to grow about 13 percent this year, to just over $24 billion — was once notorious for making cheap knockoffs of Western medicines and selling them in developing countries. But India, seasoned in the basics of medicine making, is now starting to take on a more mainstream role in the global drug industry, as a result of recent strengthening of patent law here and cost pressures on name-brand drug makers in the West," the New York Times writes.

Clovis Oncology reports net loss of $15.7 million for second quarter 2012

Clovis Oncology, Inc. today reported financial results for the second quarter 2012, and provided an update on the progress of its clinical development programs and expected milestones for the rest of the year.

Bush says he will sign PEPFAR reauthorization

President Bush on Saturday during his weekly radio address said he is eager to sign legislation (HR 5501) that would reauthorize the President's Emergency Plan for AIDS Relief through 2013, the AP/Google.com reports (Reichmann, AP/Google.com, 7/26).

Read more News

› Verified 7 days ago


Family Medicine Doctors in Columbia, TN

Gavin Butler Pinkston, MD
Family Medicine
Medicare: Accepting Medicare Assignments
Practice Location: 1222 Trotwood Ave Ste 108, Columbia, TN 38401
Phone: 931-380-4066    
Jennifer Ficke,
Family Medicine
Medicare: Not Enrolled in Medicare
Practice Location: 1040 N James M Campbell Blvd Ste 101, Columbia, TN 38401
Phone: 931-840-9991    
Dr. Tanika M. Pinn, M.D.
Family Medicine
Medicare: Medicare Enrolled
Practice Location: 1114 W 7th St, Columbia, TN 38401
Phone: 931-388-9706    Fax: 931-490-1062
Thomas W Farmer, M.D.
Family Medicine
Medicare: May Accept Medicare Assignments
Practice Location: 854 W James Campbell Blvd, Suite 403, Columbia, TN 38401
Phone: 931-380-0075    Fax: 931-388-7502
Charles A Ball, M.D.
Family Medicine
Medicare: Medicare Enrolled
Practice Location: 854 W James Campbell Blvd, Suite 403, Columbia, TN 38401
Phone: 931-380-0075    Fax: 931-388-7502
Ms. Indu Bali, MD
Family Medicine
Medicare: Accepting Medicare Assignments
Practice Location: 1394 Hatcher Lane, Suite A, Columbia, TN 38401
Phone: 931-388-9388    Fax: 931-388-9808

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.